Shandong Buchang Pharmaceuticals (603858.SH) subsidiary Drugman Diabetes Capsules approved as the first Chinese medicine secondary protected variety.

Shandong Buchang Pharmaceuticals (603858.SH) has issued an announcement. Recently, the website of the National Medical Products Administration released the "Announcement of Traditional Chinese Medicine Protected Varieties (No. 20) (No. 140 in 2024)", approving the drug Renzhi Jiangtang Capsules of Shandong Buchang Pharmaceuticals Co., Ltd. (referred to as "Shaanxi Buchang") as the first traditional Chinese medicine second-level protected variety. Renzhi Jiangtang Capsules is an exclusive variety of Shaanxi Buchang. This approval as a traditional Chinese medicine protected variety is a full affirmation of the clinical value, therapeutic effect, and quality of the product, strengthening the intellectual property protection of the variety. This will further enhance the market competitiveness and brand influence of Renzhi Jiangtang Capsules, increase market share, and have positive significance for the production, sales, and promotion of the product.